Malondialdehyde as a Prognostic Factor in Alcoholic Hepatitis

Area of Science:

• Hepatology
• Internal Medicine
• Biochemistry

Background:

• Alcoholic hepatitis is a severe liver disease with high mortality.
• Current prognostic scores for alcoholic hepatitis lack markers for oxidative stress.
• Lipid peroxidation, indicated by malondialdehyde (MDA), is implicated in alcoholic hepatitis pathogenesis.

Purpose of the Study:

• To evaluate the short-term prognostic value of malondialdehyde (MDA) and cytokines in severe alcoholic hepatitis.
• To compare the accuracy of MDA and established prognostic scores in predicting mortality.

Main Methods:

• Sixty-two patients with severe alcoholic hepatitis (Maddrey index >32) were studied.
• Prognostic scores (Maddrey, MELD, ABIC, Lille, Glasgow, MELD-Na, Child-Pugh) were calculated.
• Serum MDA and cytokine levels (IL-6, IL-8, IL-4, TNF-α, IFN-γ) were measured at admission and after 1 week.

Main Results:

• Twenty-four out of sixty-two patients died during the follow-up period.
• Malondialdehyde (MDA) demonstrated superior prognostic accuracy compared to all tested scores.
• MDA's predictive value was significant both at admission and after one week of treatment.

Conclusions:

• Malondialdehyde (MDA) assessment should be incorporated into the prognostic evaluation of alcoholic hepatitis.
• MDA levels provide valuable insights into short-term outcomes for patients with severe alcoholic hepatitis.
• Oxidative stress markers like MDA are crucial for improving patient management and predicting prognosis.